Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Stopped Participant enrollment was negatively impacted by medical oncology treatment with systemic therapy alone and accrual to other clinical trials.

Conditions

• Oligometastatic Disease

Interventions

• RADIATION: Stereotactic Radiosurgery (SRS)
• DRUG: Chemotherapy

Sponsor

Steven Burton